Home/Filings/4/0001437749-19-019280
4//SEC Filing

Latour Wouter 4

Accession 0001437749-19-019280

CIK 0000072444other

Filed

Sep 29, 8:00 PM ET

Accepted

Sep 30, 6:11 PM ET

Size

7.5 KB

Accession

0001437749-19-019280

Insider Transaction Report

Form 4
Period: 2019-09-30
Latour Wouter
DirectorPresident and Chief Executive
Transactions
  • Purchase

    Common stock

    2019-09-30$0.30/sh+166,667$50,000166,667 total
  • Purchase

    Common Stock Purchase Warrant

    2019-09-30$0.30/sh+166,667$50,000166,667 total
    Exercise: $0.30From: 2019-09-30Exp: 2024-09-30Common Stock (166,667 underlying)
Footnotes (1)
  • [F1]Each share of common stock was purchased together with a common warrant to purchase one share of the Issuer's common stock at the combined purchase price of $0.30. The Reporting Person may not exercise any portion of the common warrant to the extent that he would beneficially own more than 4.99% of the outstanding common stock immediately after exercise, except that upon at least 61 days' prior notice from the Reporting Person to the Issuer, he may increase the amount of beneficial ownership of outstanding stock after exercising his common warrants up to 9.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the common warrants.

Issuer

Vaxart, Inc.

CIK 0000072444

Entity typeother

Related Parties

1
  • filerCIK 0001652203

Filing Metadata

Form type
4
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 6:11 PM ET
Size
7.5 KB